Eli Kalif
2021
In 2021, Eli Kalif earned a total compensation of $3.5M as Executive Vice President, Chief Financial Officer at Teva Pharmaceutical Industries, a 5% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $715,340 |
|---|---|
| Salary | $747,175 |
| Stock Awards | $1,799,996 |
| Other | $282,472 |
| Total | $3,544,983 |
Kalif received $1.8M in stock awards, accounting for 51% of the total pay in 2021.
Kalif also received $715.3K in non-equity incentive plan, $747.2K in salary and $282.5K in other compensation.
Rankings
In 2021, Eli Kalif's compensation ranked 3,766th out of 12,415 executives tracked by ExecPay. In other words, Kalif earned more than 69.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,766 out of 12,415 | 70th |
Division Manufacturing | 1,537 out of 5,505 | 72nd |
Major group Chemicals And Allied Products | 623 out of 2,375 | 74th |
Industry group Drugs | 552 out of 2,096 | 74th |
Industry Pharmaceutical Preparations | 387 out of 1,546 | 75th |
Source: SEC filing on April 13, 2022.
Kalif's colleagues
We found four more compensation records of executives who worked with Eli Kalif at Teva Pharmaceutical Industries in 2021.
2021
Kåre Schultz
Teva Pharmaceutical Industries
Chief Executive Officer
2021
Sven Dethlefs
Teva Pharmaceutical Industries
Executive Vice President, North America Commercial
2021
Eric Drap
Teva Pharmaceutical Industries
Executive Vice President, Global Operations
2021
Mark Sabag
Teva Pharmaceutical Industries